 | • レポートコード：D0804-16055 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、120ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、微生物叢の世界市場を広く調査・分析し、今後の市場展望をまとめております。微生物叢の種類別市場規模（消化管マイクロバイオーム、泌尿生殖器マイクロバイオーム、皮膚マイクロバイオーム、呼吸器マイクロバイオーム、その他）、用途別市場規模（検査、治療、診断、技術基盤、プロバイオティクス、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：4D Pharma、Synlogic、Ferring、Enterome BioScience、Seres Therapeutics、Evelo Biosciences、Vedanta、Second Genome、Osel、Synthetic Biologics and Vedanta Biosciences、Metabiomics、Symberix、Rebiotix、Symbiotix Biotherapies、Ritter Pharmaceuticals、Metabogen、ActoGeniX、Miomics、AvidBiotics、Enterologics、MicroBiome Therapeutics LLC、SciBac Inc ・地域別グローバル市場分析 2015年-2020年 ・微生物叢の北米市場（アメリカ、カナダ、メキシコ） ・微生物叢のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・微生物叢のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・微生物叢の南米市場（ブラジル、アルゼンチン） ・微生物叢の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：消化管マイクロバイオーム、泌尿生殖器マイクロバイオーム、皮膚マイクロバイオーム、呼吸器マイクロバイオーム、その他 ・用途別分析：検査、治療、診断、技術基盤、プロバイオティクス、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Microbiomes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Microbiomes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Microbiomes market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Microbiomes market has been segmented into:
Gastrointestinal Microbiome
Genitourinary Microbiome
Skin Microbiome
Respiratory Microbiome
Other
By Application, Microbiomes has been segmented into:
Testing
Treatment
Diagnosis
Technology Platform
Probiotics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Microbiomes market presented in the report. This section sheds light on the sales growth of different regional and country-level Microbiomes markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Microbiomes market.
The report offers in-depth assessment of the growth and other aspects of the Microbiomes market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Microbiomes Market Share Analysis
Microbiomes competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Microbiomes sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Microbiomes sales, revenue and market share for each player covered in this report.
The major players covered in Microbiomes are:
4D Pharma
Synlogic
Ferring
Enterome BioScience
Seres Therapeutics
Evelo Biosciences
Vedanta
Second Genome
Osel
Synthetic Biologics and Vedanta Biosciences
Metabiomics
Symberix
Rebiotix
Symbiotix Biotherapies
Ritter Pharmaceuticals
Metabogen
ActoGeniX
Miomics
AvidBiotics
Enterologics
MicroBiome Therapeutics LLC
SciBac Inc
Among other players domestic and global, Microbiomes market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Microbiomes Market Overview
1.1 Product Overview and Scope of Microbiomes
1.2 Classification of Microbiomes by Type
1.2.1 Global Microbiomes Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Microbiomes Revenue Market Share by Type in 2019
1.2.3 Gastrointestinal Microbiome
1.2.4 Genitourinary Microbiome
1.2.5 Skin Microbiome
1.2.6 Respiratory Microbiome
1.2.7 Other
1.3 Global Microbiomes Market by Application
1.3.1 Overview: Global Microbiomes Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Testing
1.3.3 Treatment
1.3.4 Diagnosis
1.3.5 Technology Platform
1.3.6 Probiotics
1.3.7 Other
1.4 Global Microbiomes Market by Regions
1.4.1 Global Microbiomes Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Microbiomes (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Microbiomes Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Microbiomes Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Microbiomes Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Microbiomes Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Microbiomes Status and Prospect (2015-2025)
2 Company Profiles
2.1 4D Pharma
2.1.1 4D Pharma Details
2.1.2 4D Pharma Major Business
2.1.3 4D Pharma SWOT Analysis
2.1.4 4D Pharma Product and Services
2.1.5 4D Pharma Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.2 Synlogic
2.2.1 Synlogic Details
2.2.2 Synlogic Major Business
2.2.3 Synlogic SWOT Analysis
2.2.4 Synlogic Product and Services
2.2.5 Synlogic Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ferring
2.3.1 Ferring Details
2.3.2 Ferring Major Business
2.3.3 Ferring SWOT Analysis
2.3.4 Ferring Product and Services
2.3.5 Ferring Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.4 Enterome BioScience
2.4.1 Enterome BioScience Details
2.4.2 Enterome BioScience Major Business
2.4.3 Enterome BioScience SWOT Analysis
2.4.4 Enterome BioScience Product and Services
2.4.5 Enterome BioScience Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.5 Seres Therapeutics
2.5.1 Seres Therapeutics Details
2.5.2 Seres Therapeutics Major Business
2.5.3 Seres Therapeutics SWOT Analysis
2.5.4 Seres Therapeutics Product and Services
2.5.5 Seres Therapeutics Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.6 Evelo Biosciences
2.6.1 Evelo Biosciences Details
2.6.2 Evelo Biosciences Major Business
2.6.3 Evelo Biosciences Product and Services
2.6.4 Evelo Biosciences Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.7 Vedanta
2.7.1 Vedanta Details
2.7.2 Vedanta Major Business
2.7.3 Vedanta Product and Services
2.7.4 Vedanta Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.8 Second Genome
2.8.1 Second Genome Details
2.8.2 Second Genome Major Business
2.8.3 Second Genome Product and Services
2.8.4 Second Genome Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.9 Osel
2.9.1 Osel Details
2.9.2 Osel Major Business
2.9.3 Osel Product and Services
2.9.4 Osel Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.10 Synthetic Biologics and Vedanta Biosciences
2.10.1 Synthetic Biologics and Vedanta Biosciences Details
2.10.2 Synthetic Biologics and Vedanta Biosciences Major Business
2.10.3 Synthetic Biologics and Vedanta Biosciences Product and Services
2.10.4 Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.11 Metabiomics
2.11.1 Metabiomics Details
2.11.2 Metabiomics Major Business
2.11.3 Metabiomics Product and Services
2.11.4 Metabiomics Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.12 Symberix
2.12.1 Symberix Details
2.12.2 Symberix Major Business
2.12.3 Symberix Product and Services
2.12.4 Symberix Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.13 Rebiotix
2.13.1 Rebiotix Details
2.13.2 Rebiotix Major Business
2.13.3 Rebiotix Product and Services
2.13.4 Rebiotix Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.14 Symbiotix Biotherapies
2.14.1 Symbiotix Biotherapies Details
2.14.2 Symbiotix Biotherapies Major Business
2.14.3 Symbiotix Biotherapies Product and Services
2.14.4 Symbiotix Biotherapies Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ritter Pharmaceuticals
2.15.1 Ritter Pharmaceuticals Details
2.15.2 Ritter Pharmaceuticals Major Business
2.15.3 Ritter Pharmaceuticals Product and Services
2.15.4 Ritter Pharmaceuticals Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.16 Metabogen
2.16.1 Metabogen Details
2.16.2 Metabogen Major Business
2.16.3 Metabogen Product and Services
2.16.4 Metabogen Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.17 ActoGeniX
2.17.1 ActoGeniX Details
2.17.2 ActoGeniX Major Business
2.17.3 ActoGeniX Product and Services
2.17.4 ActoGeniX Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.18 Miomics
2.18.1 Miomics Details
2.18.2 Miomics Major Business
2.18.3 Miomics Product and Services
2.18.3 Miomics Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.19 AvidBiotics
2.19.1 AvidBiotics Details
2.19.2 AvidBiotics Major Business
2.19.3 AvidBiotics Product and Services
2.19.4 AvidBiotics Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.20 Enterologics
2.20.1 Enterologics Details
2.20.2 Enterologics Major Business
2.20.3 Enterologics Product and Services
2.20.4 Enterologics Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.21 MicroBiome Therapeutics LLC
2.21.1 MicroBiome Therapeutics LLC Details
2.21.2 MicroBiome Therapeutics LLC Major Business
2.21.3 MicroBiome Therapeutics LLC Product and Services
2.21.4 MicroBiome Therapeutics LLC Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
2.22 SciBac Inc
2.22.1 SciBac Inc Details
2.22.2 SciBac Inc Major Business
2.22.3 SciBac Inc Product and Services
2.22.4 SciBac Inc Microbiomes Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Microbiomes Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Microbiomes Players Market Share
3.2.2 Top 10 Microbiomes Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Microbiomes Revenue and Market Share by Regions
4.2 North America Microbiomes Revenue and Growth Rate (2015-2020)
4.3 Europe Microbiomes Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Microbiomes Revenue and Growth Rate (2015-2020)
4.5 South America Microbiomes Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Microbiomes Revenue and Growth Rate (2015-2020)
5 North America Microbiomes Revenue by Countries
5.1 North America Microbiomes Revenue by Countries (2015-2020)
5.2 USA Microbiomes Revenue and Growth Rate (2015-2020)
5.3 Canada Microbiomes Revenue and Growth Rate (2015-2020)
5.4 Mexico Microbiomes Revenue and Growth Rate (2015-2020)
6 Europe Microbiomes Revenue by Countries
6.1 Europe Microbiomes Revenue by Countries (2015-2020)
6.2 Germany Microbiomes Revenue and Growth Rate (2015-2020)
6.3 UK Microbiomes Revenue and Growth Rate (2015-2020)
6.4 France Microbiomes Revenue and Growth Rate (2015-2020)
6.5 Russia Microbiomes Revenue and Growth Rate (2015-2020)
6.6 Italy Microbiomes Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Microbiomes Revenue by Countries
7.1 Asia-Pacific Microbiomes Revenue by Countries (2015-2020)
7.2 China Microbiomes Revenue and Growth Rate (2015-2020)
7.3 Japan Microbiomes Revenue and Growth Rate (2015-2020)
7.4 Korea Microbiomes Revenue and Growth Rate (2015-2020)
7.5 India Microbiomes Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Microbiomes Revenue and Growth Rate (2015-2020)
8 South America Microbiomes Revenue by Countries
8.1 South America Microbiomes Revenue by Countries (2015-2020)
8.2 Brazil Microbiomes Revenue and Growth Rate (2015-2020)
8.3 Argentina Microbiomes Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Microbiomes by Countries
9.1 Middle East & Africa Microbiomes Revenue by Countries (2015-2020)
9.2 Saudi Arabia Microbiomes Revenue and Growth Rate (2015-2020)
9.3 UAE Microbiomes Revenue and Growth Rate (2015-2020)
9.4 Egypt Microbiomes Revenue and Growth Rate (2015-2020)
9.5 South Africa Microbiomes Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Microbiomes Revenue and Market Share by Type (2015-2020)
10.2 Global Microbiomes Market Forecast by Type (2019-2024)
10.3 Gastrointestinal Microbiome Revenue Growth Rate (2015-2025)
10.4 Genitourinary Microbiome Revenue Growth Rate (2015-2025)
10.5 Skin Microbiome Revenue Growth Rate (2015-2025)
10.6 Respiratory Microbiome Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Microbiomes Market Segment by Application
11.1 Global Microbiomes Revenue Market Share by Application (2015-2020)
11.2 Microbiomes Market Forecast by Application (2019-2024)
11.3 Testing Revenue Growth (2015-2020)
11.4 Treatment Revenue Growth (2015-2020)
11.5 Diagnosis Revenue Growth (2015-2020)
11.6 Technology Platform Revenue Growth (2015-2020)
11.7 Probiotics Revenue Growth (2015-2020)
11.8 Other Revenue Growth (2015-2020)
12 Global Microbiomes Market Size Forecast (2021-2025)
12.1 Global Microbiomes Market Size Forecast (2021-2025)
12.2 Global Microbiomes Market Forecast by Regions (2021-2025)
12.3 North America Microbiomes Revenue Market Forecast (2021-2025)
12.4 Europe Microbiomes Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Microbiomes Revenue Market Forecast (2021-2025)
12.6 South America Microbiomes Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Microbiomes Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Microbiomes Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Microbiomes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Microbiomes Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Microbiomes Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Microbiomes Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. 4D Pharma Corporate Information, Location and Competitors
Table 7. 4D Pharma Microbiomes Major Business
Table 8. 4D Pharma Microbiomes Total Revenue (USD Million) (2017-2018)
Table 9. 4D Pharma SWOT Analysis
Table 10. 4D Pharma Microbiomes Product and Solutions
Table 11. 4D Pharma Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Synlogic Corporate Information, Location and Competitors
Table 13. Synlogic Microbiomes Major Business
Table 14. Synlogic Microbiomes Total Revenue (USD Million) (2018-2019)
Table 15. Synlogic SWOT Analysis
Table 16. Synlogic Microbiomes Product and Solutions
Table 17. Synlogic Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Ferring Corporate Information, Location and Competitors
Table 19. Ferring Microbiomes Major Business
Table 20. Ferring Microbiomes Total Revenue (USD Million) (2017-2018)
Table 21. Ferring SWOT Analysis
Table 22. Ferring Microbiomes Product and Solutions
Table 23. Ferring Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Enterome BioScience Corporate Information, Location and Competitors
Table 25. Enterome BioScience Microbiomes Major Business
Table 26. Enterome BioScience Microbiomes Total Revenue (USD Million) (2017-2018)
Table 27. Enterome BioScience SWOT Analysis
Table 28. Enterome BioScience Microbiomes Product and Solutions
Table 29. Enterome BioScience Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Seres Therapeutics Corporate Information, Location and Competitors
Table 31. Seres Therapeutics Microbiomes Major Business
Table 32. Seres Therapeutics Microbiomes Total Revenue (USD Million) (2017-2018)
Table 33. Seres Therapeutics SWOT Analysis
Table 34. Seres Therapeutics Microbiomes Product and Solutions
Table 35. Seres Therapeutics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Evelo Biosciences Corporate Information, Location and Competitors
Table 37. Evelo Biosciences Microbiomes Major Business
Table 38. Evelo Biosciences Microbiomes Total Revenue (USD Million) (2017-2018)
Table 39. Evelo Biosciences SWOT Analysis
Table 40. Evelo Biosciences Microbiomes Product and Solutions
Table 41. Evelo Biosciences Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Vedanta Corporate Information, Location and Competitors
Table 43. Vedanta Microbiomes Major Business
Table 44. Vedanta Microbiomes Total Revenue (USD Million) (2017-2018)
Table 45. Vedanta SWOT Analysis
Table 46. Vedanta Microbiomes Product and Solutions
Table 47. Vedanta Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Second Genome Corporate Information, Location and Competitors
Table 49. Second Genome Microbiomes Major Business
Table 50. Second Genome Microbiomes Total Revenue (USD Million) (2017-2018)
Table 51. Second Genome SWOT Analysis
Table 52. Second Genome Microbiomes Product and Solutions
Table 53. Second Genome Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Osel Corporate Information, Location and Competitors
Table 55. Osel Microbiomes Major Business
Table 56. Osel Microbiomes Total Revenue (USD Million) (2017-2018)
Table 57. Osel SWOT Analysis
Table 58. Osel Microbiomes Product and Solutions
Table 59. Osel Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Synthetic Biologics and Vedanta Biosciences Corporate Information, Location and Competitors
Table 61. Synthetic Biologics and Vedanta Biosciences Microbiomes Major Business
Table 62. Synthetic Biologics and Vedanta Biosciences Microbiomes Total Revenue (USD Million) (2017-2018)
Table 63. Synthetic Biologics and Vedanta Biosciences SWOT Analysis
Table 64. Synthetic Biologics and Vedanta Biosciences Microbiomes Product and Solutions
Table 65. Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Metabiomics Corporate Information, Location and Competitors
Table 67. Metabiomics Microbiomes Major Business
Table 68. Metabiomics Microbiomes Total Revenue (USD Million) (2017-2018)
Table 69. Metabiomics SWOT Analysis
Table 70. Metabiomics Microbiomes Product and Solutions
Table 71. Metabiomics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Symberix Corporate Information, Location and Competitors
Table 73. Symberix Microbiomes Major Business
Table 74. Symberix Microbiomes Total Revenue (USD Million) (2017-2018)
Table 75. Symberix SWOT Analysis
Table 76. Symberix Microbiomes Product and Solutions
Table 77. Symberix Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Rebiotix Corporate Information, Location and Competitors
Table 79. Rebiotix Microbiomes Major Business
Table 80. Rebiotix Microbiomes Total Revenue (USD Million) (2017-2018)
Table 81. Rebiotix SWOT Analysis
Table 82. Rebiotix Microbiomes Product and Solutions
Table 83. Rebiotix Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Symbiotix Biotherapies Corporate Information, Location and Competitors
Table 85. Symbiotix Biotherapies Microbiomes Major Business
Table 86. Symbiotix Biotherapies Microbiomes Total Revenue (USD Million) (2017-2018)
Table 87. Symbiotix Biotherapies SWOT Analysis
Table 88. Symbiotix Biotherapies Microbiomes Product and Solutions
Table 89. Symbiotix Biotherapies Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Ritter Pharmaceuticals Corporate Information, Location and Competitors
Table 91. Ritter Pharmaceuticals Microbiomes Major Business
Table 92. Ritter Pharmaceuticals Microbiomes Total Revenue (USD Million) (2017-2018)
Table 93. Ritter Pharmaceuticals SWOT Analysis
Table 94. Ritter Pharmaceuticals Microbiomes Product and Solutions
Table 95. Ritter Pharmaceuticals Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Metabogen Corporate Information, Location and Competitors
Table 97. Metabogen Microbiomes Major Business
Table 98. Metabogen Microbiomes Total Revenue (USD Million) (2017-2018)
Table 99. Metabogen SWOT Analysis
Table 100. Metabogen Microbiomes Product and Solutions
Table 101. Metabogen Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. ActoGeniX Corporate Information, Location and Competitors
Table 103. ActoGeniX Microbiomes Major Business
Table 104. ActoGeniX Microbiomes Total Revenue (USD Million) (2017-2018)
Table 105. ActoGeniX SWOT Analysis
Table 106. ActoGeniX Microbiomes Product and Solutions
Table 107. ActoGeniX Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Miomics Microbiomes Type and Application
Table 109. Miomics Microbiomes Major Business
Table 110. Miomics Microbiomes Total Revenue (USD Million) (2017-2018)
Table 111. Miomics SWOT Analysis
Table 112. Miomics Microbiomes Product and Solutions
Table 113. Miomics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. AvidBiotics Corporate Information, Location and Competitors
Table 115. AvidBiotics Microbiomes Major Business
Table 116. AvidBiotics Microbiomes Total Revenue (USD Million) (2017-2018)
Table 117. AvidBiotics SWOT Analysis
Table 118. AvidBiotics Microbiomes Product and Solutions
Table 119. AvidBiotics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Enterologics Corporate Information, Location and Competitors
Table 121. Enterologics Microbiomes Major Business
Table 122. Enterologics Microbiomes Total Revenue (USD Million) (2017-2018)
Table 123. Enterologics SWOT Analysis
Table 124. Enterologics Microbiomes Product and Solutions
Table 125. Enterologics Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. MicroBiome Therapeutics LLC Corporate Information, Location and Competitors
Table 127. MicroBiome Therapeutics LLC Microbiomes Major Business
Table 128. MicroBiome Therapeutics LLC Microbiomes Total Revenue (USD Million) (2017-2018)
Table 129. MicroBiome Therapeutics LLC SWOT Analysis
Table 130. MicroBiome Therapeutics LLC Microbiomes Product and Solutions
Table 131. MicroBiome Therapeutics LLC Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. SciBac Inc Corporate Information, Location and Competitors
Table 133. SciBac Inc Microbiomes Major Business
Table 134. SciBac Inc Microbiomes Total Revenue (USD Million) (2017-2018)
Table 135. SciBac Inc SWOT Analysis
Table 136. SciBac Inc Microbiomes Product and Solutions
Table 137. SciBac Inc Microbiomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. Global Microbiomes Revenue (Million USD) by Players (2015-2020)
Table 139. Global Microbiomes Revenue Share by Players (2015-2020)
Table 140. Global Microbiomes Revenue (Million USD) by Regions (2015-2020)
Table 141. Global Microbiomes Revenue Market Share by Regions (2015-2020)
Table 142. North America Microbiomes Revenue by Countries (2015-2020)
Table 143. North America Microbiomes Revenue Market Share by Countries (2015-2020)
Table 144. Europe Microbiomes Revenue (Million USD) by Countries (2015-2020)
Table 145. Asia-Pacific Microbiomes Revenue (Million USD) by Countries (2015-2020)
Table 146. South America Microbiomes Revenue by Countries (2015-2020)
Table 147. South America Microbiomes Revenue Market Share by Countries (2015-2020)
Table 148. Middle East and Africa Microbiomes Revenue (Million USD) by Countries (2015-2020)
Table 149. Middle East and Africa Microbiomes Revenue Market Share by Countries (2015-2020)
Table 150. Global Microbiomes Revenue (Million USD) by Type (2015-2020)
Table 151. Global Microbiomes Revenue Share by Type (2015-2020)
Table 152. Global Microbiomes Revenue Forecast by Type (2021-2025)
Table 153. Global Microbiomes Revenue by Application (2015-2020)
Table 154. Global Microbiomes Revenue Share by Application (2015-2020)
Table 155. Global Microbiomes Revenue Forecast by Application (2021-2025)
Table 156. Global Microbiomes Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Microbiomes Picture
Figure 2. Global Microbiomes Revenue Market Share by Type in 2019
Figure 3. Gastrointestinal Microbiome Picture
Figure 4. Genitourinary Microbiome Picture
Figure 5. Skin Microbiome Picture
Figure 6. Respiratory Microbiome Picture
Figure 7. Other Picture
Figure 8. Microbiomes Revenue Market Share by Application in 2019
Figure 9. Testing Picture
Figure 10. Treatment Picture
Figure 11. Diagnosis Picture
Figure 12. Technology Platform Picture
Figure 13. Probiotics Picture
Figure 14. Other Picture
Figure 15. Global Microbiomes Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Microbiomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Microbiomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Microbiomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Microbiomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Microbiomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Microbiomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Microbiomes Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Microbiomes Revenue Market Share in 2019
Figure 24. Global Top 10 Players Microbiomes Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Microbiomes Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Microbiomes Revenue Market Share by Regions (2015-2020)
Figure 28. Global Microbiomes Revenue Market Share by Regions in 2018
Figure 29. North America Microbiomes Revenue and Growth Rate (2015-2020)
Figure 30. Europe Microbiomes Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Microbiomes Revenue and Growth Rate (2015-2020)
Figure 32. South America Microbiomes Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Microbiomes Revenue and Growth Rate (2015-2020)
Figure 34. North America Microbiomes Revenue Market Share by Countries (2015-2020)
Figure 35. North America Microbiomes Revenue Market Share by Countries in 2019
Figure 36. USA Microbiomes Revenue and Growth Rate (2015-2020)
Figure 37. Canada Microbiomes Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Microbiomes Revenue and Growth Rate (2015-2020)
Figure 39. Europe Microbiomes Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Microbiomes Revenue Market Share by Countries in 2019
Figure 41. Germany Microbiomes Revenue and Growth Rate (2015-2020)
Figure 42. UK Microbiomes Revenue and Growth Rate (2015-2020)
Figure 43. France Microbiomes Revenue and Growth Rate (2015-2020)
Figure 44. Russia Microbiomes Revenue and Growth Rate (2015-2020)
Figure 45. Italy Microbiomes Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Microbiomes Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Microbiomes Revenue Market Share by Countries in 2019
Figure 48. China Microbiomes Revenue and Growth Rate (2015-2020)
Figure 49. Japan Microbiomes Revenue and Growth Rate (2015-2020)
Figure 50. Korea Microbiomes Revenue and Growth Rate (2015-2020)
Figure 51. India Microbiomes Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Microbiomes Revenue and Growth Rate (2015-2020)
Figure 53. South America Microbiomes Revenue Market Share by Countries (2015-2020)
Figure 54. South America Microbiomes Revenue Market Share by Countries in 2019
Figure 55. Brazil Microbiomes Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Microbiomes Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Microbiomes Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Microbiomes Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Microbiomes Revenue and Growth Rate (2015-2020)
Figure 60. UAE Microbiomes Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Microbiomes Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Microbiomes Revenue and Growth Rate (2015-2020)
Figure 63. Global Microbiomes Revenue Share by Type (2015-2020)
Figure 64. Global Microbiomes Revenue Share by Type in 2019
Figure 65. Global Microbiomes Market Share Forecast by Type (2021-2025)
Figure 66. Global Gastrointestinal Microbiome Revenue Growth Rate (2015-2020)
Figure 67. Global Genitourinary Microbiome Revenue Growth Rate (2015-2020)
Figure 68. Global Skin Microbiome Revenue Growth Rate (2015-2020)
Figure 69. Global Respiratory Microbiome Revenue Growth Rate (2015-2020)
Figure 70. Global Other Revenue Growth Rate (2015-2020)
Figure 71. Global Microbiomes Revenue Share by Application (2015-2020)
Figure 72. Global Microbiomes Revenue Share by Application in 2019
Figure 73. Global Microbiomes Market Share Forecast by Application (2021-2025)
Figure 74. Global Testing Revenue Growth Rate (2015-2020)
Figure 75. Global Treatment Revenue Growth Rate (2015-2020)
Figure 76. Global Diagnosis Revenue Growth Rate (2015-2020)
Figure 77. Global Technology Platform Revenue Growth Rate (2015-2020)
Figure 78. Global Probiotics Revenue Growth Rate (2015-2020)
Figure 79. Global Other Revenue Growth Rate (2015-2020)
Figure 80. Global Microbiomes Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Microbiomes Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Microbiomes Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Microbiomes Revenue Market Forecast (2021-2025)
Figure 84. Europe Microbiomes Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Microbiomes Revenue Market Forecast (2021-2025)
Figure 86. South America Microbiomes Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Microbiomes Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
微生物叢の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Microbiomes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 呼吸器病原体検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Respiratory Pathogen Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Path…
- 呼吸器用アナライザーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Respiratory Analyzer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 呼吸器合胞体ウイルス（RSV）診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Respiratory Syncytial Virus (RSV) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 小児呼吸器疾患治療の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Pediatric Respiratory Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…